We are live on ! Find out more
ESLA icon

Estrella Immunopharma
ESLA

19 hedge funds and large institutions have $32.4M invested in Estrella Immunopharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

19% more funds holding

Funds holding: 16 → 19 (+3)

13% more capital invested

Capital invested by funds: $28.7M → $32.4M (+$3.65M)

7.72% more ownership

Funds ownership: 61.23% → 68.95% (+7.7%)

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HHGC
Hunting Hill Global Capital
New York
+$2.61M
2
Nomura Holdings
Nomura Holdings
Japan
+$1.95M
3
LA
Linden Advisors
New York
+$1.64M
4
WA
Whitebox Advisors
Minnesota
+$901K
5
KIM
Karpus Investment Management
New York
+$870K

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$2.85M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.95M
3
MSU
Mizuho Securities USA
New York
-$866K
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$8.59M +$870K +87,851 +11%
ASM
2
ATW SPAC Management
New York
$3.87M – – –
BFM
3
Boothbay Fund Management
New York
$3.87M – – –
HHGC
4
Hunting Hill Global Capital
New York
$2.87M +$2.61M +263,262 +1,002%
Nomura Holdings
5
Nomura Holdings
Japan
$1.95M +$1.95M +197,000 New
CH
6
CVI Holdings
Delaware
$1.73M – – –
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$1.73M – – –
LA
8
Linden Advisors
New York
$1.64M +$1.64M +165,414 New
Goldman Sachs
9
Goldman Sachs
New York
$1.06M – – –
RCM
10
Radcliffe Capital Management
Pennsylvania
$991K – – –
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$925K – – –
WA
12
Whitebox Advisors
Minnesota
$901K +$901K +90,952 New
SSA
13
Schonfeld Strategic Advisors
New York
$664K +$465K +46,964 +235%
WRBC
14
W.R. Berkley Corp
Connecticut
$539K – – –
OFG
15
OTA Financial Group
New York
$425K +$425K +42,932 New
PCM
16
Pinz Capital Management
New York
$239K +$239K +24,100 New
LCM
17
Landscape Capital Management
New Jersey
$205K +$106K +10,730 +107%
WAM
18
Weiss Asset Management
Massachusetts
$99K – – –
Millennium Management
19
Millennium Management
New York
$99K +$99.1K +10,000 New
KPF
20
K2 Principal Fund
Ontario, Canada
– -$2.85M -287,894 Closed
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
– -$1.95M -197,000 Closed
MSU
22
Mizuho Securities USA
New York
– -$866K -88,349 Closed

ESLA Hedge Fund Activity: Q4 2021 in Review

19 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma (ESLA) for Q4 2021, worth a combined $32.4M — up 13% from $28.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ESLA positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Hunting Hill Global Capital, adding an estimated $2.61M. The largest seller was K2 Principal Fund, exiting entirely with an estimated $2.85M sold.

  • 19 institutional investors held Estrella Immunopharma (ESLA) as of Q4 2021, up from 16 in Q3 2021.
  • Funds reported $32.4M of Estrella Immunopharma stock for Q4 2021, up 13% quarter-over-quarter.
  • 6 funds opened new Estrella Immunopharma positions in Q4 2021 and 3 closed out, a net change of +3 holders.
  • The largest Estrella Immunopharma buyer in Q4 2021 was Hunting Hill Global Capital, an estimated $2.61M added.
  • The largest Estrella Immunopharma seller in Q4 2021 was K2 Principal Fund, an estimated $2.85M sold.

Based on aggregated 13F filings for Q4 2021.